Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,663 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Chen NB, Li QW, Zhu ZF, Wang YM, Cheng ZJ, Hui ZG, Guo SP, He HQ, Wang B, Huang XY, Li JB, Guo JY, Hu N, Ai XL, Zhou Y, Wang DQ, Liu FJ, Xie CM, Qiu B, Liu H. Chen NB, et al. Radiat Oncol. 2020 Nov 10;15(1):260. doi: 10.1186/s13014-020-01704-2. Radiat Oncol. 2020. PMID: 33168045 Free PMC article.
CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment.
Chen NB, Xiong M, Zhou R, Zhou Y, Qiu B, Luo YF, Zhou S, Chu C, Li QW, Wang B, Jiang HH, Guo JY, Peng KQ, Xie CM, Liu H. Chen NB, et al. Among authors: xie cm. Radiat Oncol. 2022 Nov 16;17(1):184. doi: 10.1186/s13014-022-02136-w. Radiat Oncol. 2022. PMID: 36384755 Free PMC article. Clinical Trial.
Magnetic Resonance Deep Learning Radiomic Model Based on Distinct Metastatic Vascular Patterns for Evaluating Recurrence-Free Survival in Hepatocellular Carcinoma.
Zhang C, Ma LD, Zhang XL, Lei C, Yuan SS, Li JP, Geng ZJ, Li XM, Quan XY, Zheng C, Geng YY, Zhang J, Zheng QL, Hou J, Xie SY, Lu LH, Xie CM. Zhang C, et al. Among authors: xie sy, xie cm. J Magn Reson Imaging. 2023 Oct 27. doi: 10.1002/jmri.29064. Online ahead of print. J Magn Reson Imaging. 2023. PMID: 37888871
Artificial intelligence for diagnosis and prognosis prediction of natural killer/T cell lymphoma using magnetic resonance imaging.
Zhang Y, Deng Y, Zou Q, Jing B, Cai P, Tian X, Yang Y, Li B, Liu F, Li Z, Liu Z, Feng S, Peng T, Dong Y, Wang X, Ruan G, He Y, Cui C, Li J, Luo X, Huang H, Chen H, Li S, Sun Y, Xie C, Wang L, Li C, Cai Q. Zhang Y, et al. Among authors: xie c. Cell Rep Med. 2024 May 21;5(5):101551. doi: 10.1016/j.xcrm.2024.101551. Epub 2024 May 1. Cell Rep Med. 2024. PMID: 38697104
Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study.
Chen Q, Tang L, Liu N, Han F, Guo L, Guo S, Wang J, Liu H, Ye Y, Zhang L, Liu L, Wang P, Li Y, He Q, Yang X, Tang Q, Li Y, Liang Y, Sun X, Xie C, Mo Y, Guo Y, Sun R, Mo H, Cao K, Guo X, Zeng M, Mai H, Ma J. Chen Q, et al. Among authors: xie c. Cancer Commun (Lond). 2018 Nov 1;38(1):66. doi: 10.1186/s40880-018-0330-z. Cancer Commun (Lond). 2018. PMID: 30382933 Free PMC article. Clinical Trial.
7,663 results